Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 2 (2005), Issue 7 (July)

1. Effect of presentation modality on immediate and delayed recall in individuals with Alzheimer's disease.
   Am J Speech Lang Pathol, 14(2): 144-55. [Abstract] [Full-text]
2. Sustained attention in mild Alzheimer's disease.
   Dev Neuropsychol, 28(1): 507-37. [Abstract] [Full-text]
3. A 10-item smell identification scale related to risk for Alzheimer's disease.
   Ann Neurol, 58(1): 155-60. [Abstract] [Full-text]
4. Brain activation in offspring of AD cases corresponds to 10q linkage.
   Ann Neurol, 58(1): 142-6. [Abstract] [Full-text]
5. Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?
   Ann Neurol, 58(1): 139-42. [Abstract] [Full-text]
6. Visual attention deficits in Alzheimer's disease: an fMRI study.
   Neurosci Lett, 385(1): 18-23. [Abstract] [Full-text]
7. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
   J Neurol Sci, 234(1): 47-53. [Abstract] [Full-text]
8. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
   J Neurol Sci, 234(1): 55-65. [Abstract] [Full-text]
9. N-methyl-D-aspartate receptor and apoptosis in Alzheimer's disease and multiinfarct dementia.
   J Neurosci Res, 81(2): 269-74. [Abstract] [Full-text]
10. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.
    J Biol Chem, 280(27): 25754-9. [Abstract] [Full-text]
11. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
    Arch Gen Psychiatry, 62(7): 726-33. [Abstract] [Full-text]
12. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 69-71. [Abstract] [Full-text]
13. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 62-8. [Abstract] [Full-text]
14. Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease.
    Neurocase, 11(3): 216-26. [Abstract] [Full-text]
15. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
    Neurocase, 11(3): 204-11. [Abstract] [Full-text]
16. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Med Hypotheses, 65(3): 498-500. [Abstract] [Full-text]
17. Patients with mild Alzheimer's disease attribute conceptual fluency to prior experience.
    Neuropsychologia, 43(11): 1662-72. [Abstract] [Full-text]
18. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
    Neuropathol Appl Neurobiol, 31(4): 395-404. [Abstract] [Full-text]
19. Order and disorder in conversation: encounters with dementia of the Alzheimer's type.
    Clin Linguist Phon, 19(5): 393-404. [Abstract] [Full-text]
20. Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques.
    Histochem Cell Biol, 123(6): 605-11. [Abstract] [Full-text]
21. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
    Pharmacopsychiatry, 38(4): 178-9. [Abstract] [Full-text]
22. Neurophysiological predictors of long term response to AChE inhibitors in AD patients.
    J Neurol Neurosurg Psychiatry, 76(8): 1064-9. [Abstract] [Full-text]
23. Experiences in early stage Alzheimer's disease: understanding the paradox of acceptance and denial.
    Aging Ment Health, 9(5): 430-41. [Abstract] [Full-text]
24. The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular redistribution of components correlates with neuronal vulnerability.
    Neurobiol Dis, 19(3): 427-35. [Abstract] [Full-text]
25. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Clin Neurol Neurosurg, 107(5): 396-403. [Abstract] [Full-text]
26. Amyloid-beta fibril formation is not necessarily required for microglial activation by the peptides.
    Neurochem Int, 47(5): 369-76. [Abstract] [Full-text]
27. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
    Exp Brain Res, 164(2): 205-14. [Abstract] [Full-text]
28. Possible selves of individuals with Alzheimer's disease.
    Psychol Aging, 20(2): 285-94. [Abstract] [Full-text]
29. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Brain, 128: 1790-801. [Abstract] [Full-text]
30. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
    Brain, 128: 1778-89. [Abstract] [Full-text]
31. The age-dependent relation of blood pressure to cognitive function and dementia.
    Lancet Neurol, 4(8): 487-99. [Abstract] [Full-text]
32. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
    Ann N Y Acad Sci, 1043: 211-6. [Abstract] [Full-text]
33. Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.
    Exp Aging Res, 31(3): 345-54. [Abstract] [Full-text]
34. Long-term effectiveness of spaced-retrieval memory training for older adults with probable Alzheimer's disease.
    Exp Aging Res, 31(3): 261-89. [Abstract] [Full-text]
35. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease.
    Biochem Biophys Res Commun, 334(2): 342-8. [Abstract] [Full-text]
36. Neuropsychological measures and single photon emission computed tomography in the differentiation and classification of cerebral perfusion deficits in Alzheimer's dementia.
    Int J Neurosci, 115(8): 1131-49. [Abstract] [Full-text]
37. The bad seed in Alzheimer's disease.
    Neuron, 47(2): 167-8. [Abstract] [Full-text]
38. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype.
    Microb Pathog, 39(1): 19-26. [Abstract] [Full-text]
39. The Alzheimer beta-peptide shows temperature-dependent transitions between left-handed 3-helix, beta-strand and random coil secondary structures.
    FEBS J, 272(15): 3938-49. [Abstract] [Full-text]
40. Stress proteins in Alzheimer's disease.
    Int J Hyperthermia, 21(5): 421-31. [Abstract] [Full-text]
41. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study.
    Int J Neurosci, 115(7): 965-80. [Abstract] [Full-text]
42. Analysis of regularity in the EEG background activity of Alzheimer's disease patients with Approximate Entropy.
    Clin Neurophysiol, 116(8): 1826-34. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.